United States  

J&J ordered to pay $572 mln in Oklahoma opioid case

Video Credit: Reuters Studio - Duration: 01:19s - Published
J&J ordered to pay $572 mln in Oklahoma opioid case

J&J ordered to pay $572 mln in Oklahoma opioid case

An Oklahoma judge on Monday found Johnson & Johnson liable for fueling an opioid epidemic in the state by deceptively marketing painkillers, and ordered the drugmaker to pay damages of $572 million.

Rough Cut (no reporter narration).

0
shares
ShareTweetSavePostSend
 

Judge Thad Balkman of Cleveland County District Court in Norman, Oklahoma delivered his decision in a lawsuit alleging that J&J's marketing practices helped fuel the opioid epidemic by flooding the market with painkillers.

J&J shares rose 5% following the decision.

The case brought by Oklahoma Attorney General Mike Hunter was the first to go to trial out of thousands of lawsuits filed by state and local governments against opioid manufacturers and distributors.

Hunter had been seeking to make J&J pay $17 billion to help the state address the epidemic for the next 30 years through addiction treatment and prevention programs. The trial came after Oklahoma resolved claims against OxyContin maker Purdue Pharma LP in March for $270 million and against Teva Pharmaceutical Industries Ltd in May for $85 million, leaving J&J as the lone defendant.




💡 One News Page Knowledge: Other News Mentions

Johnson & Johnson Johnson & Johnson U.S. multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

Johnson & Johnson Cease Production Of Lightening Products [Video]

Johnson & Johnson Cease Production Of Lightening Products

The corporation behind Johnson's, Neutrogena, Clean & Clear, and more has just vowed to stop selling two lines of skin-care products used for skin-lightening overseas. On June 19, in the wake of the recent Black Lives Matter uprising, Johnson & Johnson said that it will cease production of two different lines from Asian and Middle Eastern markets that were used for skin-lightening lines.

Credit: Wochit News    Duration: 00:33Published
Band-Aid to Make Black and Brown Flesh-Tone Bandages [Video]

Band-Aid to Make Black and Brown Flesh-Tone Bandages

The Johnson & Johnson-owned company plans to create a range of bandages to "embrace the beauty of diverse skin"

Credit: Cover Video STUDIO    Duration: 00:50Published
Johnson & Johnson Speeds Up Vaccine Timeline [Video]

Johnson & Johnson Speeds Up Vaccine Timeline

Johnson & Johnson plans to start testing its coronavirus vaccine candidate in humans in July. The company said it will move up the timeline by about two months to start clinical trials. Previously the aim was to enter the clinic with the vaccine in September. The study will start in the second half of July and enroll 1,045 healthy volunteers in the US and Belgium. If the vaccine works, Johnson & Johnson has already pledged to distribute it at a nonprofit rate to help end the pandemic.

Credit: Wochit News    Duration: 00:35Published
Johnson & Johnson to Begin Human Trials for COVID-19 Vaccine [Video]

Johnson & Johnson to Begin Human Trials for COVID-19 Vaccine

The early-stage human trial will begin in the second half of July as opposed to its initial forecast of September.

Credit: Cover Video STUDIO    Duration: 00:56Published
Johnson & Johnson Moves Up Dates Of Human Testing For Covid Vaccine (1) [Video]

Johnson & Johnson Moves Up Dates Of Human Testing For Covid Vaccine (1)

Johnson & Johnson is the world's largest health care company. Business Insider reports that the company plans to start testing its coronavirus vaccine candidate in humans in July. On Wednesday, Johnson & Johnson it will move up the timeline by about two months to start clinical trials. It was previously aiming for trials in September. 1,045 healthy volunteers in the US and Belgium will join the study, which starts in July.

Credit: Wochit News    Duration: 00:34Published

Oklahoma Oklahoma State in the United States

Coronavirus updates: New York City reports zero deaths for first time since March; Oklahoma records first teen death; Mexico deaths top 35K

As the coronavirus pandemic reached new highs in Florida and globally on Sunday, New York City reported zero deaths for the first time since March.

USATODAY.com

For Muscogee (Creek) Tribe in Oklahoma, at Long Last Vindication

After decades of betrayals and broken treaties, the Supreme Court ruled that much of Oklahoma is their land, after all.
NYTimes.com

Supreme Court Rules Nearly Half of Oklahoma is Indian Reservation

The 5-4 decision could reshape criminal justice in eastern Oklahoma by preventing state authorities from prosecuting Native Americans
NYTimes.com

Supreme Court gives Native Americans jurisdiction over eastern half of Oklahoma

Legal authority over virtually half of Oklahoma – home to 1.8 million residents and including Tulsa, its second-largest city – was at issue.

USATODAY.com

You Might Like


Tweets about this


Related videos from verified sources

Despite J&J's Ruling, Is the Healthcare  Sector Still a Good Investing Opportunity? [Video]

Despite J&J's Ruling, Is the Healthcare Sector Still a Good Investing Opportunity?

So, how should investors approach healthcare after a headline like a judge in Oklahoma ruling against Johnson & Johnson in an opioid case? J&J was ordered to pay $572 million to the state of Oklahoma...

Credit: The Street     Duration: 01:28Published
J&J ordered to pay $572 mln in Oklahoma opioid case [Video]

J&J ordered to pay $572 mln in Oklahoma opioid case

An Oklahoma judge on Monday found Johnson & Johnson liable for fueling an opioid epidemic in the state by deceptively marketing painkillers, and ordered the drugmaker to pay damages of $572..

Credit: Rumble     Duration: 01:20Published
KTNV Digital Extra: Ongoing opioid crisis [Video]

KTNV Digital Extra: Ongoing opioid crisis

Oklahoma is one of dozens of states suing opioid drugmakers and this case is the first state case to reach trial.

Credit: Rumble     Duration: 08:04Published